Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 270

1.

A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles.

Battah B, Chemi G, Butini S, Campiani G, Brogi S, Delogu G, Gemma S.

Molecules. 2019 Nov 29;24(23). pii: E4373. doi: 10.3390/molecules24234373.

2.

Structure-Based Optimization of Coumarin hA3 Adenosine Receptor Antagonists.

Matos MJ, Vilar S, Vazquez-Rodriguez S, Kachler S, Klotz KN, Buccioni M, Delogu G, Santana L, Uriarte E, Borges F.

J Med Chem. 2019 Dec 4. doi: 10.1021/acs.jmedchem.9b01572. [Epub ahead of print]

PMID:
31738058
3.

HLA-E-Restricted CD8+ T Lymphocytes Efficiently Control Mycobacterium tuberculosis and HIV-1 Co-Infection.

La Manna MP, Orlando V, Prezzemolo T, Di Carlo P, Cascio A, Delogu G, Poli G, Sullivan LC, Brooks AG, Dieli F, Caccamo N.

Am J Respir Cell Mol Biol. 2019 Nov 7. doi: 10.1165/rcmb.2019-0261OC. [Epub ahead of print]

PMID:
31697586
4.

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history.

Magrì S, Paduano D, Chicco F, Cingolani A, Farris C, Delogu G, Tumbarello F, Lai M, Melis A, Casula L, Fantini MC, Usai P.

World J Gastroenterol. 2019 Oct 7;25(37):5676-5686. doi: 10.3748/wjg.v25.i37.5676.

5.

Carbon nanomaterials: a new way against tuberculosis.

De Maio F, Palmieri V, De Spirito M, Delogu G, Papi M.

Expert Rev Med Devices. 2019 Oct;16(10):863-875. doi: 10.1080/17434440.2019.1671820. Epub 2019 Sep 30. Review.

PMID:
31550943
6.

Honokiol, magnolol and its monoacetyl derivative show strong anti-fungal effect on Fusarium isolates of clinical relevance.

Oufensou S, Scherm B, Pani G, Balmas V, Fabbri D, Dettori MA, Carta P, Malbrán I, Migheli Q, Delogu G.

PLoS One. 2019 Sep 4;14(9):e0221249. doi: 10.1371/journal.pone.0221249. eCollection 2019.

8.

Case Report: Multifocal Tubercular Osteomyelitis of the Spine and Bilateral Dactylitis.

Taccari F, Baldin G, Emiliozzi A, Campana L, Tamburrini E, Leone E, Delogu G, Sali M, Cauda R, Leone A, Pallavicini F.

Am J Trop Med Hyg. 2019 Sep;101(3):494-497. doi: 10.4269/ajtmh.19-0262.

PMID:
31359856
9.

IP-10 contributes to the inhibition of mycobacterial growth in an ex vivo whole blood assay.

Palucci I, Battah B, Salustri A, De Maio F, Petrone L, Ciccosanti F, Sali M, Bondet V, Duffy D, Fimia GM, Goletti D, Delogu G.

Int J Med Microbiol. 2019 Jul;309(5):299-306. doi: 10.1016/j.ijmm.2019.05.005. Epub 2019 May 22.

PMID:
31147175
10.

A Storage-Dependent Platinum Functionalization with a Commercial Pre-Polymer Useful for Hydrogen Peroxide and Ascorbic Acid Detection.

Monti P, Migheli Q, Bartiromo AR, Pauciulo A, Gliubizzi R, Marceddu S, Serra PA, Delogu G.

Sensors (Basel). 2019 May 28;19(11). pii: E2435. doi: 10.3390/s19112435.

11.

Discovery of new phthalazinones as vasodilator agents and novel pharmacological tools to study calcium channels.

Munín J, Quezada E, Viña D, Uriarte E, Delogu GL, Gil-Longo J.

Future Med Chem. 2019 Feb 25. doi: 10.4155/fmc-2018-0250. [Epub ahead of print]

PMID:
30801201
12.

HPV as a marker for molecular characterization in head and neck oncology: Looking for a standardization of clinical use and of detection method(s) in clinical practice.

Bussu F, Ragin C, Boscolo-Rizzo P, Rizzo D, Gallus R, Delogu G, Morbini P, Tommasino M.

Head Neck. 2019 Apr;41(4):1104-1111. doi: 10.1002/hed.25591. Epub 2019 Feb 12. Review.

PMID:
30747478
13.

Antifungal activity of oils macerates of North Sardinia plants against Candida species isolated from clinical patients with candidiasis.

Donadu MG, Usai D, Marchetti M, Usai M, Mazzarello V, Molicotti P, Montesu MA, Delogu G, Zanetti S.

Nat Prod Res. 2019 Jan 24:1-5. doi: 10.1080/14786419.2018.1557175. [Epub ahead of print]

PMID:
30676066
14.

Synthesis, molecular docking and cholinesterase inhibitory activity of hydroxylated 2-phenylbenzofuran derivatives.

Fais A, Kumar A, Medda R, Pintus F, Delogu F, Matos MJ, Era B, Delogu GL.

Bioorg Chem. 2019 Mar;84:302-308. doi: 10.1016/j.bioorg.2018.11.043. Epub 2018 Nov 29.

PMID:
30529848
15.

Targeting α -(1,4)-Glucosidase in Diabetes Mellitus Type 2: The Role of New Synthetic Coumarins as Potent Inhibitors.

Figueroa-Benavides C, Matos MJ, Peñaloza-Amion M, Veas R, Valenzuela-Barra G, Zapata G, Delogu G, Uriarte E, Santana L, Olea-Azar C, Delporte C.

Curr Top Med Chem. 2018;18(27):2327-2337. doi: 10.2174/1568026619666181130113033.

PMID:
30499400
16.

Vacuum-assisted closure (VAC®) systems and microbiological isolation of infected wounds.

Cozza V, Pepe G, Cintoni M, De Maio F, Tropeano G, Magalini S, Sganga G, Delogu G, Gui D.

World J Emerg Surg. 2018 Nov 20;13:53. doi: 10.1186/s13017-018-0216-z. eCollection 2018.

17.

Successful analysis of a 100 years old semen stain generating a complete DNA STR profile.

Mameli A, Scudiero CM, Delogu G, Ghiani ME.

J Forensic Leg Med. 2019 Feb;61:78-81. doi: 10.1016/j.jflm.2018.11.008. Epub 2018 Nov 19.

PMID:
30476749
18.

Graphene oxide coatings prevent Candida albicans biofilm formation with a controlled release of curcumin-loaded nanocomposites.

Palmieri V, Bugli F, Cacaci M, Perini G, Maio F, Delogu G, Torelli R, Conti C, Sanguinetti M, Spirito M, Zanoni R, Papi M.

Nanomedicine (Lond). 2018 Nov;13(22):2867-2879. doi: 10.2217/nnm-2018-0183. Epub 2018 Nov 15.

PMID:
30431405
19.

The Mycobacterial HBHA Protein: A Promising Biomarker for Tuberculosis.

De Maio F, Squeglia F, Goletti D, Delogu G.

Curr Med Chem. 2019;26(11):2051-2060. doi: 10.2174/0929867325666181029165805. Review.

PMID:
30378481
20.

Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.

Sali M, Buonsenso D, D'Alfonso P, De Maio F, Ceccarelli M, Battah B, Palucci I, Chiacchio T, Goletti D, Sanguinetti M, Valentini P, Delogu G.

J Infect. 2018 Dec;77(6):526-533. doi: 10.1016/j.jinf.2018.09.011. Epub 2018 Sep 26.

PMID:
30267797

Supplemental Content

Loading ...
Support Center